Market Tracker

07/28 4:08am ET

Heron Therapeutics Inc (NASDAQ:HRTX)

32.30
Delayed Data
As of Jul 27
 +0.55 / +1.73%
Today’s Change
6.51
Today|||52-Week Range
36.81
+221.07%
Year-to-Date
No recent news for Heron Therapeutics Inc.

Today’s Trading

Previous close31.75
Today’s open31.24
Day’s range-- - --
Volume683,157
Average volume (3 months)1,514,678
Market cap$1.1B
Dividend yield--
Data as of 07/27/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+2.96%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.72

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.26+2.63%
RPTPRaptor Pharmaceutica...-0.72-4.97%
RGENRepligen Corp+0.28+0.78%
ACHNAchillion Pharmaceut...-0.41-4.72%
Data as of 3:59pm ET, 07/27/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.65
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts